We are live on ! Find out more
Legal & General Group

Legal & General Group Portfolio holdings

AUM $432B
1-Year Est. Return 29.4%
 

Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.

This Quarter Est. Return
+0.37%
1 Year Est. Return
+29.4%
3 Year Est. Return
+97.7%
5 Year Est. Return
+129.51%
10 Year Est. Return
+472.83%
AUM
$308B
AUM Growth
+$8.55B
Cap. Flow
+$10.7B
Cap. Flow %
3.49%
Top 10 Hldgs %
21.95%
Holding
3,551
New
77
Increased
2,293
Reduced
671
Closed
55

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$657M
2
AAPL icon
Apple
AAPL
+$610M
3
AMZN icon
Amazon
AMZN
+$587M
4
AZN icon
AstraZeneca
AZN
+$319M
5
SNOW icon
Snowflake
SNOW
+$272M

Sector Composition

Rank Sector Weight
1 Technology 25.03%
2 Financials 13.72%
3 Healthcare 12.6%
4 Consumer Discretionary 10.97%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEEL
3201
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$25K ﹤0.01%
3
+1
+50% +$8.59K
GBL
3202
DELISTED
GAMCO Investors, Inc.
GBL
$25K ﹤0.01%
939
-93
-9% -$2.48K
STXB
3203
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$25K ﹤0.01%
1,028
SOLY
3204
DELISTED
Soliton, Inc.
SOLY
$25K ﹤0.01%
1,206
+235
+24% +$5.02K
LONA
3205
LeonaBio Inc
LONA
$72.3M
$24K ﹤0.01%
257
BRBS icon
3206
Blue Ridge Bankshares
BRBS
$331M
$24K ﹤0.01%
1,367
CIA icon
3207
Citizens
CIA
$191M
$24K ﹤0.01%
3,925
-4,560
-54% -$25.9K
DAWN
3208
DELISTED
Day One Biopharmaceuticals
DAWN
$24K ﹤0.01%
+1,027
New +$24.6K
FBIO icon
3209
Fortress Biotech
FBIO
$89.4M
$24K ﹤0.01%
500
FNLC icon
3210
First Bancorp
FNLC
$398M
$24K ﹤0.01%
812
GLUE icon
3211
Monte Rosa Therapeutics
GLUE
$1.34B
$24K ﹤0.01%
1,082
-1,918
-64% -$55K
GRFS
3212
Grifois
GRFS
$5.42B
$24K ﹤0.01%
1,671
GWRS icon
3213
Global Water Resources
GWRS
$219M
$24K ﹤0.01%
1,308
ICAD
3214
DELISTED
iCAD Inc
ICAD
$24K ﹤0.01%
2,268
KZR
3215
DELISTED
Kezar Life Sciences
KZR
$24K ﹤0.01%
279
LCTX icon
3216
Lineage Cell Therapeutics
LCTX
$274M
$24K ﹤0.01%
9,674
OLPX
3217
DELISTED
Olaplex Holdings
OLPX
$24K ﹤0.01%
+1,000
New +$24.5K
VOR icon
3218
Vor Biopharma
VOR
$1.28B
$24K ﹤0.01%
78
+29
+59% +$8.62K
NPKI
3219
NPK International
NPKI
$1.14B
$24K ﹤0.01%
7,152
SYRS
3220
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$24K ﹤0.01%
533
BVS icon
3221
Bioventus
BVS
$1.19B
$23K ﹤0.01%
1,630
+819
+101% +$12.6K
FHTX icon
3222
Foghorn Therapeutics
FHTX
$360M
$23K ﹤0.01%
1,673
-49
-3% -$543
INBK icon
3223
First Internet Bancorp
INBK
$255M
$23K ﹤0.01%
744
IPI icon
3224
Intrepid Potash
IPI
$470M
$23K ﹤0.01%
760
IRMD icon
3225
iRadimed
IRMD
$1.18B
$23K ﹤0.01%
672
+34
+5% +$1.16K

Similar funds

Legal & General Group's Q3 2021 Portfolio in Review

As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.

  • Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
  • Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
  • Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
  • Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
  • Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
  • Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
  • Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.

Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.